Effectiveness of a Fully Automated Mobile Therapeutic Versus a General Chatbot in Reducing Depression and Anxiety and Improving Well-Being: Feasibility Randomized Controlled Trial

Clinical Snapshot

Key Findings

• P Value: AI therapy vs control: P=.01; ChatGPT vs control: P=.02 for PHQ-9

• Effect Size: AI therapy group: d=-0.47; ChatGPT group: d=-0.44 versus control for PHQ-9

• Primary Outcome: Depression measured by PHQ-9 showed significant reduction in both intervention groups compared to control

• Nnt Or Sensitivity: Not calculable from provided data

• Confidence Interval: Not reported in abstract

Clinical Application

High attrition rates suggest implementation challenges. Structured therapeutic chatbots may be more acceptable than general chatbots Relevant to Australian digital mental health initiatives. Could complement existing services like Beyond Blue online chat. Would need TGA consideration for therapeutic claims and integration with Medicare-funded digital mental health programs Adults with mild to moderate depression and anxiety symptoms seeking digital mental health interventions

Abstract

BACKGROUND: Given the increasing prevalence of depression and anxiety disorders and enduring barriers to care, there is a critical need for alternative treatment options. Generative artificial intelligence (AI) chatbots show promise for increasing access to mental health care, though more direct research is needed to establish their efficacy. OBJECTIVE: This pilot study aimed to test the efficacy of a generative mental health chatbot rooted in solution-focused therapy compared to the general-purpose ChatGPT and an assessment-only control (AOC) group on depression, anxiety, and well-being. METHODS: A total of 185 English-speaking adults were recruited online and randomly assigned to one of three groups: AI therapy, ChatGPT, or AOC. Of these, 147 eligible participants filled out a pretreatment assessment. Over a 3-week period, the AI therapy group (n=44) was instructed to complete 3 structured, fully automated app-based sessions per week (9 total), while the ChatGPT group (n=60) was instructed to engage in 9 unstructured conversations with ChatGPT (GPT-4o-based models). The control group (n=43) received no intervention. In the AI therapy group, 39% (n=17) completed all sessions, as did 62% (n=38) of those in the ChatGPT group. Primary outcome measures, self-assessed online at baseline and postintervention, included the Patient Health Questionnaire-9 (PHQ-9), Overall Depression Severity and Impairment Scale (ODSIS) (depression), 7-item Generalized Anxiety Disorder Scale (anxiety), and World Health Organization Well-Being Index (5-item version) (well-being). Linear mixed effects models were used for data analysis. RESULTS: Compared to AOC, both the AI therapy group (d=-0.47; P=.01) and the ChatGPT group (d=-0.44; P=.02) demonstrated significant reductions in depression scores measured by PHQ-9. The AI therapy group showed nonsignificant reductions in anxiety (d=-0.37; P=.11) and ODSIS depression scores (d=-0.25; P=.22) and an increase in well-being (d=0.12; P=.53) compared to AOC. Similarly, a nonsignificant reduction in anxiety (d=-0.27; P=.22) and ODSIS depression scores (d=-0.12; P=.53) and an increase in well-being (d=0.20; P=.29) were observed in the ChatGPT group compared to AOC. The AI therapy group did not significantly outperform the ChatGPT group on any outcomes (PHQ-9: b=-0.19; d=0.03; P=.87; 7-item Generalized Anxiety Disorder Scale: b=-0.57; d=-0.11; P=.62; ODSIS: b=-0.59; d=-0.13; P=.50; and WHO: b=-0.38; d=-0.07; P=.69). CONCLUSIONS: Both the structured generative AI chatbot and ChatGPT showed a significant reduction in depression scores compared to the control group. No significant effects were observed across other outcomes, although descriptive trends indicated improvements in anxiety. While the AI therapy group showed descriptively better outcomes for depression and anxiety, differences between groups were not significant. A larger sample and longer intervention may be needed for the emerging trends to yield clinically meaningful effect sizes.

References

1. 1.Kuta, B., Novak, L., Zidkova, R., Furstova, J., Malinakova, K., De Winter, A., & Husek, V. (2026). Effectiveness of a Fully Automated Mobile Therapeutic Versus a General Chatbot in Reducing Depression and Anxiety and Improving Well-Being: Feasibility Randomized Controlled Trial. JMIR Mental Health. https://doi.org/10.17605/OSF.IO/BPS58